HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INTERLEUKIN-6 INHIBITORS AND JANUS KINASE INHIBITORS Conference Poster 2024 Congress communication